当前位置：首页 SCI 期刊医学 Emerging Microbes & Infections(非官网)

Emerging Microbes & InfectionsSCIE

国际简称：EMERG MICROBES INFEC 参考译名：新兴微生物和感染

中科院分区
2区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：2222-1751; E-ISSN：2222-1751; 是否OA：开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：ENGLAND; 出版商：Springer Nature; 出版语言：English; 出版周期：1 issue/year; 出版年份：2012; 研究方向：IMMUNOLOGY-MICROBIOLOGY

评价信息：: 影响因子：8.4; H-index：31; CiteScore指数：26.2; SJR指数：2.316; SNIP指数：1.653

发文数据：: Gold OA文章占比：95.91%; 研究类文章占比：95.59%; 年发文量：227; 自引率：0.0227...; 开源占比：0.9586; 出版撤稿占比：0; 出版国人文章占比：0.33; OA被引用占比：0.9983...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Emerging Microbes & Infections期刊介绍

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

期刊简介Emerging Microbes & Infections期刊介绍

《Emerging Microbes & Infections》自2012出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 20 Weeks
国际TOP期刊
医学
INFECTIOUS DISEASES
SCIE
中科院2区
非预警

Cite Score数据（2024年最新版）Emerging Microbes & Infections Cite Score数据

CiteScore：26.2
SJR：2.316
SNIP：1.653

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Drug Discovery	Q1	3 / 157	98%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Parasitology	Q1	2 / 79	98%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Infectious Diseases	Q1	9 / 344	97%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Microbiology	Q1	6 / 182	96%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Epidemiology	Q1	6 / 148	96%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Virology	Q1	4 / 80	95%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology	Q1	13 / 236	94%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Emerging Microbes & Infections 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	2区	INFECTIOUS DISEASES 传染病学 IMMUNOLOGY 免疫学 MICROBIOLOGY 微生物学	1区 2区 2区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Emerging Microbes & Infections JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	16 / 181	91.4%
学科：INFECTIOUS DISEASES	SCIE	Q1	8 / 132	94.3%
学科：MICROBIOLOGY	SCIE	Q1	14 / 161	91.6%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	7 / 181	96.41%
学科：INFECTIOUS DISEASES	SCIE	Q1	5 / 132	96.59%
学科：MICROBIOLOGY	SCIE	Q1	8 / 161	95.34%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND371
USA172
GERMANY (FED REP GER)58
England49
France44
Australia37
Netherlands25
South Korea21
Canada19
Sweden18

本刊中国学者近年发表论文

1、Epidemiological characteristics and molecular features of carbapenem-resistant Enterobacter strains in China: a multicenter genomic study
Author: Zhu, Zhichen; Xie, Xiaofang; Yu, Hua; Jia, Wei; Shan, Bin; Huang, Bin; Qu, Fen; Niu, Siqiang; Lv, Jinnan; Gao, Qizhao; Qian, Feinan; Tian, Xiangxiang; Zhai, Yaxuan; Wen, Yicheng; Yang, Chengcheng; Zhu, Jie; Tang, Yiwei; Chen, Liang; Du, Hong

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2148562
2、Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
Author: Zhu, Liguo; Mao, Naiying; Yi, Changhua; Simayi, Aidibai; Feng, Jialu; Feng, Yi; He, Min; Ding, Songning; Wang, Yin; Wang, Yan; Wei, Mingwei; Hong, Jie; Li, Chuchu; Tian, Hua; Zhou, Lu; Peng, Jiefu; Zhang, Shihan; Song, Ci; Jin, Hui; Zhu, Fengcai; Xu, Wenbo; Zhao, Jun; Bao, Changjun

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2146535
3、Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020
Author: Zhou, Ziqi; Ali, Abraham; Walelign, Elias; Demissie, Getnet F.; El Masry, Ihab; Abayneh, Takele; Getachew, Belayneh; Krishnan, Pavithra; Ng, Daisy Y. M.; Gardner, Emma; Makonnen, Yilma; Miguel, Eve; Chevalier, Veronique; Chu, Daniel K.; So, Ray T. Y.; Von Dobschuetz, Sophie; Mamo, Gezahegne; Poon, Leo L. M.; Peiris, Malik

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2164218
4、Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
Author: Zhong, Guohua; Zhuang, Chunlan; Hu, Xiaowen; Chen, Qi; Bi, Zhaofeng; Jia, Xinhua; Peng, Siying; Li, Yufei; Huang, Yue; Zhang, Qiufen; Hong, Ying; Qiao, Youlin; Su, Yingying; Pan, Huirong; Wu, Ting; Wei, Lihui; Huang, Shoujie; Zhang, Jun; Xia, Ningshao

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2185456
5、Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
Author: Zheng, Xubin; Gui, Xuwei; Yao, Lan; Ma, Jun; He, Yifan; Lou, Hai; Gu, Jin; Ying, Ruoyan; Chen, Liping; Sun, Qin; Liu, Yidian; Ho, Chih-Ming; Lee, Bai-Yu; Clemens, Daniel L.; Horwitz, Marcus A.; Ding, Xianting; Hao, Xiaohui; Yang, Hua; Sha, Wei

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2187247
6、Rational development of multicomponent mRNA vaccine candidates against mpox
Author: Zhang, Rong-Rong; Wang, Zheng-Jian; Zhu, Yi-Long; Tang, Wei; Zhou, Chao; Zhao, Suo-Qun; Wu, Mei; Ming, Tao; Deng, Yong-Qiang; Chen, Qi; Jin, Ning-Yi; Ye, Qing; Li, Xiao; Qin, Cheng-Feng

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192815
7、Integrated analysis reveals important differences in the gut and oropharyngeal microbiota between children with mild and severe hand, foot, and mouth disease
Author: Zhang, Nan; Mou, Danlei; Li, Tongzeng; Chen, Zhiyun; Ma, Chunhua; Liang, Lianchun; He, Qiushui

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192819
8、Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles
Author: Zhang, Nailou; Tan, Zhongyuan; Wei, Jinbo; Zhang, Sai; Liu, Yan; Miao, Yuanjiu; Ding, Qingwen; Yi, Wenfu; Gan, Min; Li, Chunjie; Liu, Bin; Wang, Hanzhong; Zheng, Zhenhua

Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2174777